*|MC_PREVIEW_TEXT|*

Broader Prostate Screening, AI Use Jumps, and FDA Clears New AI Apps
November 16, 2026
site logo

Together with

partner logo

“In PE-backed teleradiology, ‘independent’ is a waystation, not an end state.”

Seth Crapp, MD, commenting on recent consolidation in the teleradiology sector.

In the era of all-in-one radiology technology stacks, what’s the value of dedicated breast imaging workflow software? A new contribution from Densitas shows how a specialist breast imaging platform can help providers manage the specialized needs of mammography practices while avoiding duplicate data entry and conflicting patient communications. Check it out now. 

Meanwhile, radiology has outgrown the infrastructure it runs on, with imaging practices experiencing fragmented workflows, delayed reads, and radiologists spending time on work that isn’t image interpretation. In this contribution from RamSoft, learn how one connected platform can help radiologists read more studies without increasing their workload. 

How can medical imaging practices build a foundation for better, more intelligent connections across their radiology workflows? We talked to Jonathon Dreyer of Microsoft about the possibilities in this episode of The Imaging Wire Show. Check it out on our YouTube channel. 

– Brian Casey, Managing Editor

AGFA HealthCare  •  Altamont Software  •  CARPL.ai  •  DeepHealth  •  Enlitic  •  Fujifilm  •  GE HealthCare  •  Intelerad  •  Kailo Medical  •  Mach7 Technologies  •  Medality  •  Medicom  •  Merge  •  Mosaic Clinical Technologies  •  Philips  •  Quibim  •  Rad AI  •  RealTime Medical  •  Riverain Technologies  •  Scanslated  •  Sectra  •  United Imaging  •  Us2.ai  •  Visage Imaging

Prostate Cancer Imaging

Broader Prostate Screening Supported in ACS Guidelines

In a major boost for broader prostate cancer screening, the American Cancer Society last week issued new guidelines that support PSA screening every two years for average-risk men ages 50 through 69 years. The new guidelines include advice on using MRI to avoid unnecessary biopsies, underscoring the modality’s role in making prostate screening more precise. 

Of all the major cancer screening tests, prostate screening has seen perhaps the greatest swings in utilization. 

  • PSA screening took off in the 1990s following the FDA’s approval of the first blood tests for measuring PSA levels. 

But enthusiasm for screening waned in the 2000s. Clinicians learned that prostate cancer is often a slow-growing disease, and many men were being biopsied and treated for cancer that didn’t pose a health threat.

  • Prostate screening soon became the poster child for overdiagnosis, leading the USPSTF to discourage widespread PSA utilization in 2012.

The pendulum soon began swinging back, as prostate cancer incidence and mortality began rising due to lower rates of PSA screening. 

  • Clinicians and public health advocates soon realized that PSA testing had a role to play, it just needed to be used more judiciously. 

And that’s where MRI comes in. Recent clinical studies have shown that MRI can be used to determine which men with elevated PSA levels should be biopsied and which ones can be followed with active surveillance.  

  • The evidence has become so strong that it even convinced the Cochrane Group – historically no friend to new medical tests and screening exams  – to reverse course in May and recommend PSA screening.

Which brings us to the ACS recommendation. In addition to recommending PSA screening every two years, the group offered advice for men with high PSA levels (≥ 3 ng/mL for those younger than 70, ≥ 6.5 ng/mL for those 70 and older). 

  • Men with persistently high PSA levels on follow-up tests should get MRI scans and/or biomarker tests. 

And even in men diagnosed with cancer, immediate treatment could be deferred if it’s found that the cancer is at low risk of metastasis. Here too, MRI can play a role by supporting active surveillance.

  • The new guidelines don’t mention prostate AI, but recent research has shown that it can help make MRI even more precise, reducing unnecessary biopsies and detecting cancers that might have been missed by radiologists. 

The Takeaway

The new ACS guidelines on prostate screening are welcome news – the question now is whether the USPSTF will follow suit. The group is currently reviewing its (somewhat lukewarm) 2018 guidance, but given recent turmoil there’s no telling how long that will take. 

United Imaging at RSNA 2026

At RSNA 2026, United Imaging will be featuring new technology in all modalities. You’ll be able to see the latest and greatest, review images, and meet leadership. Visit them at Booth #1932 to learn how their Passion for Change makes a difference.

sponsor logo

AI Echo for Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy is a leading cause of sudden cardiac death in the young. It is now treatable in the era of cardiac myosin inhibitors, yet remains substantially underdiagnosed. Learn how AI echo with Us2.ai can help.

sponsor logo

Implementation Speed and Radiologist Burnout

Join Merge Chief Medical Officer Raj Chopra, MD, for a webinar on November 17 at 1 PM ET addressing how the speed of implementing imaging workflow solutions is fueling radiologist burnout – and what to do about it. Reserve your seat today.

sponsor logo

The Wire

  • AI Use Jumps Among Clinicians: Physician AI use jumped 34 percentage points in the last year, with 85% using AI at least weekly versus 51% last year. That’s according to the latest survey from Doximity, which queried 3.4k U.S. doctors on their AI utilization. Oncologists led the way with 93% reporting either daily or weekly use, followed by gastroenterology, nephrology, and neurology. Interestingly, radiology placed 10th on the list at 87%, even though 76% of all FDA AI authorizations are for radiology products.
  • AI for Intracranial Aneurysms: AI can detect incidental findings on radiology reports, and a new study in JACR explores another method for closing the loop. New York researchers used the Aidoc Patient Management AI application to analyze radiology reports of brain CT angiography scans and flag cases with signs of intracranial aneurysm. Out of 57.6k scans, AI flagged 6.1k (11%) cases that received further analysis to determine if they should be followed up. Eventually, 35 patients got diagnostic angiograms and 14 underwent neurosurgical procedures.  
  • FDA Clears AI for Brain Aneurysm Detection: Meanwhile, a new AI tool for detecting brain aneurysms is now available after the FDA cleared Uptunity | Aneurysm, an algorithm developed by Avicenna.AI and Bracco. The solution is designed to be used as a concurrent aid for radiologists reading CT angiography images to detect and assess aneurysms in the cerebral arteries. It is the first product in the Uptunity portfolio being developed by the companies through a partnership announced in March. 
  • Echo AI Calculates Heart Age: Mayo Clinic researchers used UltraSight’s echocardiography AI software to estimate “heart age,” finding that people with older scores had worse clinical outcomes. In a study of 568 people presented at the ESC Digital & AI Summit 2026, every five-year increase in the gap between chronological heart age and AI-calculated age was associated with a 61% increase in cardiovascular/dementia mortality over 20 years. AI-calculated heart age metrics could identify at-risk people long before symptoms occur. 
  • Naitive Gets FDA Nod for Spine AI: Naitive Technologies is expanding the clinical applications for its AI-based bone health assessment software after receiving FDA clearance for OsteoSight Spine. The solution enables opportunistic assessment of bone mineral density using routine X-rays of the lumbar spine, thoracic spine, and chest that were ordered for other indications. Naitive in 2025 received FDA clearance for its flagship OsteoSight software for assessing BMD from hip and pelvis X-rays. 
  • Clarity Gets Breakthrough Nod for PSMA Tracer: A radiopharmaceutical for prostate PSMA-PET scans being developed by Clarity Pharmaceuticals received FDA Breakthrough Therapy Designation. Clarity’s Cu-64 SAR-bisPSMA is being developed to detect PSMA-positive lesions in men with suspected prostate cancer recurrence based on elevated PSA levels. Clarity is conducting two phase III clinical trials – AMPLIFY and CLARITY – to support an FDA submission, with results expected in the first half of 2027. 
  • Altamont Updates eForms Software: Altamont Software released an update for its eForms solution that enables historical measurement values and clinical observations to be displayed alongside current values. The update means radiologists and technologists no longer have to search through historical data to find prior measurements. In addition, Altamont made its Dynamic Content engine available within eForms, making it easier to perform real-time calculations and automatically generate report content. 
  • RADPAIR Partners with Novarad: RADPAIR signed an agreement with Novarad that makes RADPAIR’s cloud-based agentic AI reporting technology available within Novarad’s NovaPACS enterprise image management software. RADPAIR will operate as an integrated component of NovaPACS, giving radiologists a single connected workflow for reviewing images, accessing priors, and generating and finalizing radiology reports. RADPAIR has been growing its stable of PACS partners as it seeks broader distribution of its agentic AI technology. 
  • Chinese Radiopharma Firm Raises $60M: A Chinese company developing radiopharmaceuticals for diagnostic and therapeutic applications raised $60M in a Series A funding round. Eli Radiopharma said the funds would be used to advance the company’s portfolio of radiopharmaceuticals, several of which are nearing IND submission. The company is working on agents ranging from a fluorine-18 PET tracer for diagnosing neurological diseases to theranostics candidates that combine diagnostics and treatment. 
  • Agfa Radiology Launches New Mobile X-Ray: Agfa Radiology is launching DR 100s Pro, a new mobile X-ray system, at RSNA 2026. The system is designed to be easier for technologists to use, while including Agfa features like its Musica Xpert image processing, wireless inductive detector charging, and SmartXR technologist workflow assistance. Technologists who have badged in can launch exams by scanning patient wristbands, with Musica handling image quality adjustments.
  • DeepLook Touts Mammography Findings: Breast imaging visualization firm DeepLook Medical is highlighting findings from a U.K. study in which its DL Precise technology was used to enhance diagnostic mammography images. Across 400 cases that included women with dense breast tissue, radiologist confidence improved (from 61% to 66%), suggesting higher sensitivity in interpreting cancers obscured by dense tissue. Specificity remained unchanged, indicating no increase in false positives. Researchers plan to submit the study for publication.  
  • Fuzion Updates Workflow Software: Workflow software developer Fuzion Technologies released an update to its flagship medical imaging workflow solution. RadFuzion performs tasks that often require separate applications, like routing studies between modalities, PACS, and AI nodes, and includes a RadRead module for covering hours when a cloud-based PACS or RIS is down. Version 6.8.6 makes the application available on Linux for x64 and ARM64 servers, and also lets administrators limit a RadRead user to the facilities they serve, enforced on the server. 
  • Learning Radiology Is Child’s Play: Radiology’s ongoing workforce shortage means it’s a good idea to introduce young people to the specialty even before they start university. In an article in Academic Radiology, Austrian researchers describe a novel way to do it with MagnetXplorers, an interactive mystery game targeted at students aged 16 to 19 years. Working in classroom-sized groups, players are tasked with diagnosing a fictional animal called Arkynox, and are introduced to basic medical imaging concepts as they try to solve puzzles and unlock boxes. 

See Clearly. Decide Confidently

Streamline reading time, improve accuracy, and quantify population health metrics in cardiothoracic imaging with powerful AI tools from Riverain Technologies. See how their ClearRead solution works by booking a demo at RSNA 2026 or stopping by Booth #4741.

sponsor logo

The Right Data, Ready When You Are

Kailo Medical will be at RSNA 2026 at Booth #5141 in the South Hall with four demo stations and a private room for team sessions. Request a time now to confirm a slot that fits your week in Chicago.

sponsor logo

Experience Imaging as One

 At RSNA 2026, experience one unified enterprise imaging platform from AGFA HealthCare, bringing together workflow orchestration, streaming, cloud, AI, and interoperability. Book a meeting or visit them at Booth #2119.

sponsor logo

The Resource Wire

  • See Mosaic Reporting live at RSNA 2026: Mosaic Reporting uses ambient AI and large language models to help radiologists create structured reports faster, alongside your existing PACS. Visit Booth #5304 in the South Hall AI Showcase or book a private demo on the Mosaic RSNA Event Hub. 
  • Connectivity Solutions at RSNA 2026: Visit Altamont Software at RSNA 2026 to learn more about their full portfolio of connectivity solutions, from Passport SR for capturing DICOM Structured Report measurements to eForms for eliminating paper-based workflow. Book a meeting today or stop by at Booth #7808.
  • Helping Clinicians Work More Efficiently: Philips is helping clinicians work more efficiently with Elevate Plus for the EPIQ Elite and Affiniti ultrasound systems, featuring technology designed to reduce variability, support reproducible results, and facilitate timely clinical decision-making. Learn more at RSNA 2026. 
  • Heading to RSNA 2026? See how Scanslated’s solution – powered by real clinical expertise, not AI – turns confusing radiology reports into patient-friendly explanations, cutting through the misinformation and anxiety patients face interpreting reports alone. Schedule a virtual demo or book a time to stop by Booth #2809.
  • Unified Workflows From Image to Clinical Decision: Join Intelerad, a GE HealthCare company, on Tuesday, November 17 at 2 PM ET to discover how they are connecting imaging everywhere ahead of RSNA 2026. See how their solutions, including IntelePACS, InteleOrchestrator, and InteleShare, connect imaging and clinical information. 
  • See Why Leading Health Systems Choose Rad AI at RSNA: Yale, Emory, and Radiologic Associates of Fredericksburg are rethinking radiology reporting with Rad AI. Discover what’s driving the move beyond legacy platforms. Schedule a meeting.
  • Centered on Innovation. Shaped by Experience: Visit Fujifilm at RSNA 2026 to see how their advanced solutions built on over 90 years of medical imaging experience can help meet your imaging needs. Book a meeting or stop by at Booth #4100. 
  • Bring Your Hardest Imaging Question to Chicago: Mach7 Technologies delivers your imaging data, working for patient care. Everywhere it’s needed, ready for AI, under your control. You’ll find eUnity and the Mach7 vendor-neutral archive running live at RSNA 2026 – book a meeting or stop by Booth #4116. 
  • Data that’s Correct, Complete, and Consistent: ENDEX from Enlitic standardizes your DICOM imaging data with AI precision, so every study is labeled right and ready to use. Learn how it can benefit your radiology practice today. 
  • Experience What Matters Most: Visit GE HealthCare at RSNA 2026 to explore innovations across imaging, AI, software, services, and pharmaceutical diagnostics. Connect with experts, experience demonstrations, and discover new technologies by requesting a meeting today, or visit Booth #7330.
  • Experience the Platform for the Future at RSNA: Visage is not only leading imaging’s move to the cloud, they’ve defined it. Book at priority demo with them at RSNA 2026 or visit Booth #4329 to experience the platform for the future – powered by speed.
  • A New Resource for Radiology Jobs: Check out the new Job Boards from Medality to gain access to newly posted positions for radiologists, residents, and fellows. If you’re an employer, post your first job for no charge to reach Medality’s network of over 40,000 monthly users. 
  • The Value of an AI Ecosystem: CARPL helps healthcare providers realize the value of the entire AI ecosystem. Learn how it can benefit you by booking a meeting at RSNA 2026, or drop by at Booth #5311.
  • Your RSNA Starts Here: Whether you’re visiting RSNA 2026 to solve a specific challenge or to explore what’s possible, Sectra’s team will be there for you. Book a demo to discover how their enterprise imaging SaaS solutions – including radiology reporting – can meet your imaging needs.
  • Rethinking Imaging Interoperability: Image sharing is becoming an interoperability and governance problem. Join Medicom and Medidata at RSNA 2026 for a look at a new model being implemented at a large integrated health system to replace one-off connections with a standards-based approach.
  • Heading to RSNA? Let’s Talk Operational Transformation: Join Fujifilm at Booth #4100 to explore Synapse Worklist Orchestrator (SWO), in partnership with RealTime Medical. Discover how SWO’s Radiology Cockpit and Operations Platform takes practices beyond workflow orchestration to operational transformation, improving throughput, turnaround times, and workload equity.
  • Transforming Imaging Data into Actionable Predictions: Quibim has built a cloud-based, tissue-agnostic platform to extract key radiomics drivers from the world’s largest imaging data registries. Learn more about their portfolio at RSNA 2026 by booking a meeting today or visiting them at Booth #5111.
  • A New Standard of AI-Powered Care: Unify for your imaging experience with AI-powered solutions from DeepHealth. Book a demo today to discover the latest in integrated, cloud-native imaging and operations, or visit them at Booth #1329.  

The Industry Wire

  1. Former FDA head Makary accuses Trump aides of bowing to industry. 
  2. U.S. loses measles elimination status. 
  3. Medicaid work requirements delayed for six months.
  4. Scientists are finally starting to understand endometriosis. 
  5. Alnylam needs to solve its heart drug problem. 
  6. The real-estate billionaire spending a fortune to slow down aging. 
  7. Are cancer drugmakers quitting the immunology fight early? 
  8. How Nasdaq became biotech’s default exchange. 
  9. Tau buildup faster in brains of early Alzheimer’s patients. 
  10. ‘Sideshow’ Alzheimer’s theory makes a comeback.